Cite
HARVARD Citation
Handunnetti, S. et al. (2021). Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy. EJHaem. 2 (2), pp. 266-271. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Handunnetti, S. et al. (2021). Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy. EJHaem. 2 (2), pp. 266-271. [Online].